Adjuvant chemotherapy for resected triple negative breast cancer patients: A network meta-analysis

Adjuvant chemotherapy for resected triple negative breast cancer patients: A network meta-analysis

The current standard of care for resected early-stage triple negative breast cancer (TNBC) patients who did not receive systemic preoperative therapy is adjuvant anthracycline- and taxane-based chemotherapy (CT). A network meta-analysis (NMA) of randomized controlled trials (phase III) enrolling pat...

Full description

Bibliographic Details
Main Authors: Fausto Petrelli, Valentina Bertaglia, Maria Chiara Parati, Karen Borgonovo, Pushpamali De Silva, Andrea Luciani, Silvia Novello, Mario Scartozzi, Leisha A. Emens, Cinzia Solinas
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:Breast
Subjects:
Resected triple negative breast cancer
Adjuvant therapy
Network meta-analysis
Capecitabine
Prognosis
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977622001965

Internet

http://www.sciencedirect.com/science/article/pii/S0960977622001965

Similar Items